Advertisement
Screener

NASDAQ:AKTX | Debt Instrument, Convertible, Beneficial Conversion Feature | Akari Therapeutics Plc

0.5 / 5 stars · 13/120 Roast Me

Akari Therapeutics Plc Debt Instrument, Convertible, Beneficial Conversion Feature

Discontinued › Balance Sheet › Liabilities › Debt › Debt Instruments

us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2014-03-24

Period endDebt Instrument, Convertible, Beneficial Conversion Feature 12 month
2012-12-31$250.00K
20-F · filed 2014-03-24